Correlation between severity and SMN protein level in spinal muscular atrophy.
about
Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAsAlternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophyWRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodiesMolecular and therapeutic potential and toxicity of valproic acidSMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophySMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophyModeling spinal muscular atrophy in DrosophilaSurvival motor neuron protein regulates stem cell division, proliferation, and differentiation in DrosophilaGemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gemsCoiled bodies and gems: Janus or gemini?Gemin4. A novel component of the SMN complex that is found in both gems and nucleoliDrug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIIDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy type IDrug treatment for spinal muscular atrophy types II and IIIThe splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophyThe zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomicsZPR1 is essential for survival and is required for localization of the survival motor neurons (SMN) protein to Cajal bodies.SMN interacts with a novel family of hnRNP and spliceosomal proteinsIntragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number.Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein.SMN transcript levels in leukocytes of SMA patients determined by absolute real-time PCRCoilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy proteinThe contribution of mouse models to understanding the pathogenesis of spinal muscular atrophyIndoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanismHeterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissuesA SMN missense mutation complements SMN2 restoring snRNPs and rescuing SMA miceA functional interaction between the survival motor neuron complex and RNA polymerase IICopy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative DiseasesMolecular Mechanisms of Neurodegeneration in Spinal Muscular AtrophyHomeostatic plasticity at the Drosophila neuromuscular junctioniPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease DevelopmentApplicability of histone deacetylase inhibition for the treatment of spinal muscular atrophyStem cell transplantation for motor neuron disease: current approaches and future perspectivesSplicing therapy for neuromuscular diseaseSkeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA)Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy.
P2860
Q21142695-887CAA55-C513-4C9C-8F6C-FED967C37033Q21144988-831A1504-39B5-4748-A6AE-29DE184D60C9Q21145787-0341D1AA-79F0-486E-8B57-6B6A00213E70Q21296867-889667AF-B818-4BCF-8F77-9816483EB5FEQ21560963-16BA8F88-7589-42CA-B353-C59C85B1CF4AQ21562176-43415707-09B2-4713-A6ED-8CB914AE8777Q21562542-7F85884A-5935-45C3-8725-14314EC5FBA7Q21563387-8F5D6E12-9C96-4FD2-A79F-2BACD0D2ED74Q22010941-C421AD25-ACCF-4D94-B5EA-FB95ABA61678Q22066143-BFFE01C0-1609-45A6-8299-2192CA6CD70AQ22253358-CB71209C-5DF0-47C5-8842-CEA19B814261Q24200270-A6995030-8F1C-4B54-94A3-712230467EEBQ24200377-DA422B80-0A57-41E9-B996-79040883688DQ24234414-A7352F9E-AF21-4E0E-8D82-0D29E82A6712Q24234523-1742421A-03AB-4540-94B1-CC06E089707AQ24241017-19E88CBB-8897-478E-AC3A-1262EE4132EEQ24241759-A5F2B448-342D-4EA9-AB01-AE9EA2ADB629Q24301061-D8EC0B38-2750-490E-B1F1-C3FB51C925A3Q24307665-AD0E314B-7765-40CF-8898-92A2477126E5Q24311585-CDFBBE60-D6C6-4561-BE4A-8D06C2D3381BQ24519083-E8F9BBA8-11E6-4819-9EDC-96B7AC633F74Q24535803-D6487479-F832-4299-8EA0-E34221F6F622Q24539804-D2E89764-B842-4522-96AA-E701AC33D363Q24540057-965B9241-02CF-43B0-B088-A51EB8916A16Q24599124-15205D22-2F75-48BC-BD09-68344FEB4A0EQ24600358-3BD70406-13EC-4D9C-AFDE-D438672C5880Q24604444-CF4C1EBF-B022-4A6E-8C9C-8F9C98CDE5E2Q24613087-E0746E10-8551-400C-AC0E-CCEF6185F772Q24651106-CA03BC03-B15E-48DB-8C71-CA8337CF641CQ24657021-A18C19D3-9F3D-405A-AB73-520713983132Q24674951-1BBA8D04-CD55-4A59-8A01-5DA0C6BACC9CQ26750803-15336318-58EB-4103-8A2A-D6E8766E62B9Q26752798-9F435A1E-D54D-417F-84A5-6B1E11DD8A0DQ26829672-8CBF6990-506B-497A-8F20-B112DF09802CQ26863612-C5583257-047D-4EF1-B2BB-6E08642553AAQ26864605-14F6B132-FD79-43CE-B103-27EE97DE0F12Q26995278-50D8D668-4CA3-40E8-8F40-0A49DC77EA6EQ27009581-1D8A014A-8B20-4827-B25C-98631795E8B7Q27312220-B5699B6D-ECDF-4196-9649-14EB6DE62671Q27328843-EEBC5364-B5FE-45B3-98EC-180580047D87
P2860
Correlation between severity and SMN protein level in spinal muscular atrophy.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Correlation between severity and SMN protein level in spinal muscular atrophy.
@en
type
label
Correlation between severity and SMN protein level in spinal muscular atrophy.
@en
prefLabel
Correlation between severity and SMN protein level in spinal muscular atrophy.
@en
P2093
P356
P1433
P1476
Correlation between severity and SMN protein level in spinal muscular atrophy.
@en
P2093
Bertrandy S
Clermont O
Dreyfuss G
Lefebvre S
P2860
P2888
P304
P356
10.1038/NG0797-265
P407
P577
1997-07-01T00:00:00Z
P5875
P6179
1051068967